Maybe just the markets lack of vision. We've been here for CDI prevention and we know how important and big 004 will be if the microbiome protective effect is significant. But Mr.Market really liked the AAD endpoint and may be showing his disappointment in those results right now. CDI goal is looking great. If development continues to prove that goal, 004 is a winner. It just might take a while for the larger investment community to recognize that.
News 
Market Data 
Discover 
